Home

Zevra Therapeutics, Inc. - Common Stock (ZVRA)

7.9500
-0.0700 (-0.87%)

Zevra Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with rare diseases and complex disorders

The company leverages advanced scientific research to address unmet medical needs, particularly in the areas of neurological and metabolic conditions. Through its commitment to cutting-edge innovation and patient-centered solutions, Zevra Therapeutics aims to improve the quality of life for individuals affected by challenging health conditions, fostering hope and enhancing treatment options in the biotech landscape.

SummaryNewsPress ReleasesChartHistoricalFAQ